212 related articles for article (PubMed ID: 14730897)
21. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 4. Opioid receptor binding properties of 8-[N-(4'-phenyl)-phenethyl)carboxamido] analogues of cyclazocine and ethylketocycalzocine.
Wentland MP; VanAlstine M; Kucejko R; Lou R; Cohen DJ; Parkhill AL; Bidlack JM
J Med Chem; 2006 Sep; 49(18):5635-9. PubMed ID: 16942039
[TBL] [Abstract][Full Text] [Related]
22. The stimulatory effect of mu- and delta-opioid receptors on bovine pinealocyte melatonin synthesis.
Chuchuen U; Ebadi M; Govitrapong P
J Pineal Res; 2004 Nov; 37(4):223-9. PubMed ID: 15485547
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
Lester PA; Traynor JR
Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205
[TBL] [Abstract][Full Text] [Related]
24. Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism.
Balboni G; Salvadori S; Guerrini R; Negri L; Giannini E; Bryant SD; Jinsmaa Y; Lazarus LH
J Med Chem; 2004 Jul; 47(16):4066-71. PubMed ID: 15267245
[TBL] [Abstract][Full Text] [Related]
25. Exploiting the Power of Stereochemistry in Drug Action: 3-[(2
Turnaturi R; Pasquinucci L; Chiechio S; Grasso M; Marrazzo A; Amata E; Dichiara M; Prezzavento O; Parenti C
ACS Chem Neurosci; 2020 Apr; 11(7):999-1005. PubMed ID: 32186844
[TBL] [Abstract][Full Text] [Related]
26. Electrophilic gamma-lactone kappa-opioid receptor probes. Analogues of 2'-hydroxy-2-tetrahydrofurfuryl-5,9-dimethyl-6,7-benzomorphan diastereomers.
Klein P; Nelson WL
J Med Chem; 1991 Aug; 34(8):2438-44. PubMed ID: 1652019
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and SAR study of opioid receptor ligands: mono- and bis-indolomorphinans.
Li F; Yin C; Chen J; Liu J; Xie X; Zhang A
Chem Biol Drug Des; 2009 Oct; 74(4):335-42. PubMed ID: 19691470
[TBL] [Abstract][Full Text] [Related]
28. 2,5-Dimethyl-2'-hydroxy-9 alpha- and 9 beta-(3-methylbutyl)-6,7-benzomorphans and N-substituted compounds in the 9 alpha-(3-methylbutyl) series: chemistry, pharmacology, and biochemistry.
Jacobson AE; Rice KC; Burke TR; Lupinacci L; Mattson MV; Aceto MD; Harris LS
J Pharm Sci; 1987 Mar; 76(3):248-52. PubMed ID: 3035172
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a series of N-alkyl benzomorphans in cell lines expressing transfected delta- and mu-opioid receptors.
Abood ME; Noel MA; Carter RC; Harris LS
Biochem Pharmacol; 1995 Sep; 50(6):851-9. PubMed ID: 7575648
[TBL] [Abstract][Full Text] [Related]
30. Neuropeptide VF-associated satiety involves mu and kappa but not delta subtypes of opioid receptors in chicks.
Cline MA; Sliwa LN
Neurosci Lett; 2009 May; 455(3):195-8. PubMed ID: 19429120
[TBL] [Abstract][Full Text] [Related]
31. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and characterizations of novel quinoline derivatives having mixed ligand activities at the kappa and mu receptors: Potential therapeutic efficacy against morphine dependence.
Deb I; Paira P; Hazra A; Banerjee S; Dutta PK; Mondal NB; Das S
Bioorg Med Chem; 2009 Aug; 17(16):5782-90. PubMed ID: 19640720
[TBL] [Abstract][Full Text] [Related]
33. Antipodal alpha-N-(methyl through decyl)-N-normetazocines (5,9 alpha-dimethyl-2'-hydroxy-6,7-benzomorphans): in vitro and in vivo properties.
May EL; Aceto MD; Bowman ER; Bentley C; Martin BR; Harris LS; Medzihradsky F; Mattson MV; Jacobson AE
J Med Chem; 1994 Sep; 37(20):3408-18. PubMed ID: 7932569
[TBL] [Abstract][Full Text] [Related]
34. Characterization of opioid-binding sites in zebrafish brain.
González-Núñez V; Barrallo A; Traynor JR; Rodríguez RE
J Pharmacol Exp Ther; 2006 Feb; 316(2):900-4. PubMed ID: 16207834
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and pharmacological evaluation of novel octahydro-1H-pyrido[1,2-a]pyrazine as mu-opioid receptor antagonists.
Le Bourdonnec B; Goodman AJ; Graczyk TM; Belanger S; Seida PR; DeHaven RN; Dolle RE
J Med Chem; 2006 Dec; 49(25):7290-306. PubMed ID: 17149859
[TBL] [Abstract][Full Text] [Related]
36. Cyprodime analogues: synthesis and pharmacological evaluation.
Schmidhammer H; Smith CF; Erlach D; Koch M; Krassnig R; Schwetz W; Wechner C
Prog Clin Biol Res; 1990; 328():37-40. PubMed ID: 2154795
[No Abstract] [Full Text] [Related]
37. Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists.
Miller DK; Lever JR; Rodvelt KR; Baskett JA; Will MJ; Kracke GR
Drug Alcohol Depend; 2007 Jul; 89(2-3):282-91. PubMed ID: 17368966
[TBL] [Abstract][Full Text] [Related]
38. Development of novel LP1-based analogues with enhanced delta opioid receptor profile.
Pasquinucci L; Turnaturi R; Prezzavento O; Arena E; Aricò G; Georgoussi Z; Parenti R; Cantarella G; Parenti C
Bioorg Med Chem; 2017 Sep; 25(17):4745-4752. PubMed ID: 28734666
[TBL] [Abstract][Full Text] [Related]
39. An investigation of the N-demethylation of 3-deoxymorphine and the affinity of the alkylation products to mu, delta, and kappa receptors.
Csutoras C; Zhang A; Bidlack JM; Neumeyer JL
Bioorg Med Chem; 2004 May; 12(10):2687-90. PubMed ID: 15110850
[TBL] [Abstract][Full Text] [Related]
40. Opioid profiles of Cys2-containing enkephalin analogues.
Pencheva N; Milanov P; Vezenkov L; Pajpanova T; Naydenova E
Eur J Pharmacol; 2004 Sep; 498(1-3):249-56. PubMed ID: 15364002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
